The epithelial Na ϩ channel (ENaC) is tightly regulated by sodium intake to maintain whole body sodium homeostasis. In addition, ENaC is inhibited by high levels of intracellular Na ϩ [Na ϩ ]i, presumably to prevent cell Na ϩ overload and swelling. However, it is not clear if this regulation is relevant in vivo. We show here that in rats, an acute (4 h) oral sodium load decreases whole-cell amiloride-sensitive currents (INa) in the cortical collecting duct (CCD) even when plasma aldosterone levels are maintained high by infusing the hormone. This was accompanied by decreases in whole-kidney cleaved ␣-ENaC (2.6 fold), total ␤-ENaC (1.7 fold), and cleaved ␥-ENaC (6.2 fold). In addition, cell-surface ␤-and ␥-ENaC expression was measured using in situ biotinylation. There was a decrease in cell-surface core-glycosylated (2.2 fold) and maturely glycosylated (4.9 fold) ␤-ENaC and cleaved ␥-ENaC (4.7 fold). There were no significant changes for other apical sodium transporters. To investigate the role of increases in Na ϩ entry and presumably [Na ϩ ]i on ENaC, animals were infused with amiloride prior to and during sodium loading. Blocking Na ϩ entry did not inhibit the effect of resalting on INa. However, amiloride did prevent decreases in ENaC expression, an effect that was not mimicked by hydrochlorothiazide administration. Na ϩ entry and presumably [Na ϩ ]i can regulate ENaC expression but does not fully account for the aldosterone-independent decrease in I Na during an acute sodium load. Na channel; Na transporters; amiloride; intracellular Na THE MAMMALIAN KIDNEY plays an integral role in maintaining whole body sodium homeostasis by regulating the amount of sodium that is reabsorbed from the glomerular filtrate. The aldosterone-sensitive distal nephron (ASDN) serves as the final site of sodium reabsorption and plays a key role in matching sodium intake with excretion. The epithelial Na ϩ channel (ENaC) mediates sodium entry across the apical membrane and is thought to be the predominant site for regulating sodium reabsorption in the ASDN (7, 19, 21, 27, 28) . The mineralocorticoid aldosterone serves as a signal to increase ENaC activity in response to a low-Na diet by increasing channel activity as well as overall and apical surface expression of ENaC subunits (23, 26, 45) . With an acute sodium load, serum aldosterone levels rapidly decrease with a concomitant decrease in ENaC activity and expression (12, 27) . However, it is unknown if the decrease in aldosterone is necessary for downregulating ENaC activity under these conditions.
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During an acute sodium load, there is a rapid increase in urinary sodium excretion. This is likely to enhance Na ϩ entry in the ENaC-expressing cells due to increased Na ϩ delivery to the ASDN. The rate of sodium entry could serve as another signal to downregulate ENaC activity. Previous studies found that inhibiting sodium entry with amiloride in isolated toad bladder (40) and rat CCD (18) increases sodium channel activity. Conversely, inhibiting basolateral efflux of Na ϩ in frog skin (24) , toad urinary bladder (11) (22, 41) , frog skin (13, 24, 43) , and rat CCD (18, 37) , as well as in ENaC-expressing oocytes (1) (2) (3) . These studies show that [Na ϩ ] i can decrease both ENaC open probability (2) and cell-surface expression (44) . However, the roles of feedback inhibition by [Na ϩ ] i in regulating channel activity and cellsurface expression in vivo have yet to be elucidated.
Here we investigate the roles of decreased aldosterone and increased [Na ϩ ] i in regulating ENaC and other sodium transporters during an acute sodium load.
METHODS

Animals.
All procedures using animals were approved by the Institutional Animal Care and Use Committee of Weill Cornell Medical College. Female Sprague-Dawley rats (Charles Rivers Laboratories, Kingston, NY) weighing from 200 to 300 g were raised free of viral infections. We concentrated on females in this study because their anatomy facilitated the perfusion required for the in vivo biotinylation technique. We cannot rule out sex differences in the renal responses that we have observed, although we have no specific indications for such variation. Rats were maintained on a Na-deficient rat diet containing 0.004% Na by weight (MP Biomedicals, Solon, OH) for 7 days. Aldosterone osmotic pumps (model 2002, Alza, Palo Alto, CA) were implanted subcutaneously 5 days after initiation of Na-deficient diet to increase levels of circulating aldosterone. Aldosterone was dissolved in polyethylene glycol 300 at 2 mg/ml to give a calculated infusion rate of 1 g/h. On the day of the experiment, rats were given access to deionized H 2O or 150 mM NaCl saline solution for 4 h. In some animals, amiloride-filled osmotic pumps were implanted 30 min before the saline drinking water was offered. Amiloride was dissolved in polyethylene glycol 300 at 64 mg/ml to give a calculated infusion rate of 32 g/h. Sham surgery was performed on resalted comparisons. In another group of animals, hydrochlorothiazide was dissolved in DMSO and injected intraperitoneally at 4 mg/kg body wt before resalting.
In situ biotinylation. The protocol was described in detail previously (14) . In summary, rats were anesthetized with Inactin (100 mg/kg) intraperitoneally and placed on ice. The abdominal cavity was opened and the aorta cannulated below the renal arteries. The kidneys were perfused by gravity at a rate of ϳ10 ml/min. The vena cava was punctured to allow fluid outflow. The aorta was then ligated above the renal arteries. The animal was killed by opening the chest and cutting the cardiac apex. The abdominal cavity was kept at Ͻ7°C with a steady stream of ice-cold 150 mM NaCl solution over the kidneys. Flow rates through the urethra were 0.2-0.5 ml/min. At this point, the left renal artery and vein were ligated and the kidney removed for electrophysiological studies.
The right kidney was perfused first for 10 -15 min with PBS (in mM: 140 NaCl, 4.5 KCl, 10 Na 2HPO4) at pH 8.0, containing heparin, for 20 -25 min with PBS ϩ 0.5 mg/ml sulfosuccinimidyl-2-[biotinamido]ethyl-1,3-dithiopropionate(sulfo-NHS-biotin, Pierce Chemical), and finally for 30 min with TBS (in mM: 120 NaCl, 4.5 KCl, 25 Tris), at pH 8.0, to quench the reaction of the reagent with the tissue and remove excess biotin.
The right kidney was removed, minced with a razor blade, and homogenized with a tight-fitting Dounce in 8 ml of lysis buffer [in mM: 250 sucrose, 10 triethanolamine, and 60 l protease inhibitors cocktail (Sigma-Aldrich)] at pH 7.4. The homogenate was centrifuged for 10 min at 1,000 g to separate intact cells and nuclei. The supernatant was centrifuged at 17,000 g for 2 h to sediment a total membrane fraction. This pellet was resuspended in 2 ml of lysis buffer, aliquoted, and frozen at Ϫ80°C. Protein concentrations were measured with a BCA kit (Pierce). For isolation of biotinylated proteins, 3 mg of protein were solubilized in 0.5 ml of solubilization buffer [in mM: 100 mM NaCl, 50 mM Tris, 5 mM EDTA, 3% Triton X-100, 1 g/ml leupeptin (Sigma-Aldrich), 0.1 mg/ml PMSF (SigmaAldrich)] at pH 7.4 along with 0.8 ml of a 50% suspension of Neutravidin beads (Pierce Chemical) and gently rocked overnight. The beads were washed twice with solubilization buffer with 1% Triton X-100, twice with high salt solubilization buffer (in mM: 500 NaCl, 50 Tris, 5 EDTA, 0.1% Triton X-100, 1 g/ml leupeptin, 0.1 mg/ml PMSF) at pH 7.4, and twice with no-salt buffer (in mM: 10 Tris, 1 g/ml leupeptin, 0.1 mg/mL PMSF) at pH 7.4. Proteins were eluted from the beads with 45 l LDS Sample Buffer (Invitrogen) and 25 l Sample Reducing Agent (Invitrogen) at 85°C for 10 min. Twenty microliters of this cell-surface sample were loaded onto a lane of the electrophoresis gel. Whole kidney samples were prepared with 0.5 mg of protein in 65 l lysis buffer, 25 l LDS sample buffer, and 10 l Sample Reducing Agent and heated at 85°C for 8 min. Ten microliters of this mixture was loaded onto each lane of the gel.
Immunoblotting. The whole-kidney and cell-surface samples were electrophoresed on 4 -12% Bis-Tris gels (Invitrogen) and the proteins were transferred electrophoretically to PVDF membranes. After blocking with BSA, membranes were incubated overnight at 4°C with primary antibodies of ␣-, ␤-, or ␥-subunit of rENaC at 1:1,000 dilution as described in Ref. 12 . Anti-rabbit IgG conjugated with alkaline phosphatase was used as a secondary antibody. Bound antibody was visualized on autoradiography film (HyBlot CL, Denville Scientific) using a chemiluminescence substrate (Western Breeze, Invitrogen). Semiquantitative densitometry of protein bands was performed with background subtraction using AdobePhotoshop CS5. For whole kidney extracts we loaded equal amounts of total protein in each lane. We did not normalize band densities for control proteins. However, blots using the same samples probed with antibodies against the ER protein calnexin (see Fig. 4 ) or syntaxin 4 (not shown) had indicated similar protein abundances ( Ϯ 20%) in different experimental groups. For the cell-surface samples we loaded eluates obtained by extracting equal amounts of protein from each whole kidney membrane preparation.
Antibodies. Polyclonal antibodies against the ␣-, ␤-, and ␥-subunits of rat ENaC (rENaC) were based on short peptide sequences in the amino terminus of ␣-ENaC and the carboxy termini of ␤-ENaC and ␥-ENaC as described previously (12, 26) . Antisera were purified using peptide-linked agarose-bead affinity columns (Sulfolink Kit, Pierce Biotechnology). Antibodies against the Na-Cl cotransporter (NCC) were a generous gift of David Ellison (Oregon Health and Sciences Center). Antibodies against Na ϩ /H ϩ exchanger 3 (NHE3) and Na ϩ -K ϩ -2Cl-cotransporter 2 (NKCC2) were purchased from Chemicon International (Millipore, Billerica, MA).
Electrophysiology. For whole-cell clamp measurements, kidneys were sliced with a razor blade, and cortical collecting ducts were isolated with forceps and split open with a fine needle (28) . The tubules were superfused with solutions prewarmed to 37°C containing (in mM) 135 Na methanesulfonate, 5 KCl, 2 Ca methanesulfonate, 1 MgCl 2, 2 glucose, 5 Ba methanesulfonate, and 10 HEPES adjusted to pH 7.4 with NaOH. The patch-clamp pipettes were filled with solutions containing (in mM) 7 KCl, 123 aspartic acid, 20 CsOH, 20 TEAOH, 5 EGTA, 10 HEPES, 3 MgATP, and 0.3 NaGDP␤S at pH 7.4. The total concentration of K ϩ was 120 mM. Pipettes were pulled from hematocrit tubing, coated with Sylgard, and fire-polished with a microforge. Pipette resistances ranged from 2 to 5 M⍀. Amiloridesensitive currents (I Na) were measured as the difference in current with and without 10 M amiloride in the bath solution.
Statistics. Statistical significance between two groups was assessed by unpaired Student t-tests. P Ͻ 0.05 was considered significant.
RESULTS
The regulation of ENaC and other sodium transporters during acute sodium repletion was investigated using the protocol shown in Fig. 1 . Rats were fed a low-Na ϩ diet for 7 days to maximize ENaC activity and expression and then implanted with an aldosterone pump for the final 2 days to maintain serum aldosterone at a concentration previously shown to maximally activate ENaC (27) . On the day of the experiment, ]i on downregulation of ENaC during acute salt repletion. Three groups of animals were studied. All were fed a Na-deficient diet for 7 days and received aldosterone by osmotic minipump for 2 days before the experiment. "Control" animals received no further treatment. "Resalted" animals drank saline ad libitum for 4 h. "Resalted with ENaC block" animals were treated with amiloride during the 4-h Na repletion period. Comparison between the control and resalted groups assessed the effects of acute repletion with controlled levels of plasma aldosterone. Comparison between resalted and resalted with ENaC block assessed the role of Na ϩ entry in mediating the responses to acute repletion. the rats were split into three groups: 1) a control group receiving deionized drinking water, 2) a resalted group receiving drinking water with 150 mM NaCl, or 3) a resalted ϩ ENaC block group infused with amiloride via osmotic minipumps during the repletion period (Fig. 1) . Urine was collected separately for two 2-h periods and used to determine urinary Na and K excretion rates (Table 1) . After 4 h, the rats were anesthetized and electrophysiology and in situ biotinylation measurements were carried out as described in METHODS. We first tested whether a decrease in the circulating level of aldosterone is necessary for the downregulation of ENaC activity and expression during an acute sodium load by com- Fig. 2 . Whole-cell recordings from principal cells of cortical collecting ducts (CCDs) of low-Na ϩ and resalted rats with aldosterone (aldo) pumps. Representative current traces and current-voltage relationships from a low Na ϩ plus aldosterone rat (A), an acutely salt-replete rat (B), and an acutely salt-replete rat treated with amiloride (C). Fig. 3 . Amiloride-sensitive current (INa) in rat CCD of control, resalted, and resalted ϩ amiloride rats. INa was measured at Vm ϭ Ϫ100 mV in CCDs from rats under the three different physiological conditions in Fig. 2 .
A: control (low-Na and aldosterone pumps) rats had significantly higher INa than resalted rats with aldosterone pumps (*P Ͻ 0.0001, n ϭ 15 cells in each group, 3 rats in each group). B: infusion of rats with amiloride during Na ϩ repletion (n ϭ 31 cells, 4 rats) did not significantly affect INa of resalted rats with aldosterone pumps (n ϭ 30 cells, 5 rats) (P ϭ 0.3). paring control and resalted rats infused with the hormone. Consumption of saline was not controlled. However, as shown in Table 1 , urine volume, which reflects fluid intake, was large (ϳ5 ml/h) in the resalted animals. In a few cases in which the animals did not drink avidly experiments were aborted. I Na was assessed from isolated CCDs using whole-cell recordings as illustrated in Fig. 2 . There was a significant decrease (70%) in I Na measured at V m ϭ Ϫ100 mV with an acute sodium repletion in the resalted group (Fig. 3A) despite the continued presence of high levels of aldosterone from the minipumps. The decrease was similar to that observed previously in experiments in which aldosterone levels were not controlled (12) . In that case levels decreased to near those of Na-replete animals (27) . In the examples shown the reversal potentials for the amiloride-insensitive current were different for the two cells. This was highly variable due to differences in whole-cell Cl Ϫ conductance (29). In Fig. 2 the examples were chosen to have relatively small Cl Ϫ conductances. There was no significant difference in this conductance or reversal potential among groups and no correlation with I Na .
We next examined whole-kidney expression of ENaC proteins in the same groups of animals. The 70% decrease in ENaC activity was accompanied by a significant decrease in whole-kidney expression of cleaved (2.6 fold) but not uncleaved ␣-ENaC (Fig. 4, A and B) . ␤-ENaC levels also decreased by 1.6-fold (Fig. 4, C and D) . The major change appeared to be in a higher molecular mass form identified as the maturely glycosylated form (12) rather than the presumed core-glycosylated form. However, the two bands could not be clearly separated for quantitative analysis. The amount of cleaved ␥-ENaC dropped sharply (6.2 fold) with an acute sodium load (Fig. 4, E and F) . In this set of experiments, the band corresponding to uncleaved ␥-ENaC was present but too faint to quantify in either group. We do not know why this was the case here but not in similar blots shown in Fig. 8 below or in previous studies (12, 14) .
We further examined surface expression of ␤-and ␥-ENaC using the in situ biotinylation technique (14) . As previously shown (14) , biotinylated ␣-ENaC could not be isolated due to nonspecific binding of the subunit to avidin beads. At the cell surface, both the mature-(4.9 fold) and core-(2.2 fold) glycosylated forms of ␤-ENaC (Fig. 5, A and B) as well as the cleaved form of ␥-ENaC (4.7 fold) (Fig. 5, C and D) significantly decreased with acute salt repletion.
We also assessed the effect of acute sodium repletion on Na ϩ transporters located upstream of the ASDN. The 4-h sodium load with maintained aldosterone did not significantly change the whole-cell or cell-surface expression of NHE3, NKCC2, or NCC (Figs. 6 and 7 ). In the cell-surface fraction, additional higher-molecular-weight forms, possibly representing dimers, of NHE3, NKCC2, and NCC were observed consistent with a previous study (17) . The amounts of the 160-kDa and 260-kDa forms of NCC decreased modestly with acute sodium repletion but these effects were not statistically significant. To test the role of [Na ϩ ] i in regulating ENaC activity and expression under these conditions, we compared resalted and resalted ϩ amiloride rats. In the former group, increased Na ϩ delivery from upstream segments could result in increased Na ϩ entry into the principal cells through ENaC, an effect that would be blocked by amiloride in the latter group. The same dose of amiloride used in this study produced drug concentrations estimated to be 7.5 M and 19 M in the CNT and the CCD, respectively (16) . Saline consumption, estimated from the urine output, was similar in the two sets of animals ( Table 1) . The presence of amiloride in the lumen of the ASDN is confirmed by the finding of reduced K ϩ excretion, despite the larger natriuresis, in resalted ϩ amiloride rats compared with resalted rats (Table 1) . Amiloride infusion during acute sodium repletion did not significantly change I Na (Fig. 3B ). This suggests that increased Na ϩ entry into the principal cells of the CCD is not necessary to downregulate ENaC activity under these conditions.
In contrast, we observed large effects of amiloride infusion on changes in ENaC expression. Amiloride prevented decreases in whole kidney cleaved ␣-ENaC (Fig. 8, A and B) and ␥-ENaC (Fig. 8, E and F) as judged by the increased levels in the resalted ϩ amiloride vs. resalted animals. No changes in uncleaved ␣-ENaC or ␥-ENaC were observed. Amiloride did http://ajprenal.physiology.org/ not alter whole-kidney ␤-ENaC, although in these samples we could not quantify the amounts of maturely glycosylated protein (Fig. 8, C and D) . The channel blocker also protected against decreases in the cell-surface expression of core-glycosylated ␤-ENaC and cleaved ␥-ENaC by acute sodium repletion (Fig. 9) .
The effects of amiloride could have resulted from either blocking Na ϩ entry into ENaC-expressing cells or to a more efficient excretion of the Na load and therefore to a reduced volume expansion. Actual rates of Na excretion were not statistically different but were highly variable (Table 1) depending on the amount of saline the animals drank. To distinguish these possibilities we repeated the resalting protocol using hydrochlorothiazide (HCTZ) instead of amiloride. The dose of HCTZ produced a significant natriuresis in Na-depleted, nonresalted animals (data not shown). HCTZ did not diminish the effect of resalting on the expression of ␥-ENaC (Fig. 10) . In fact the expression of the cleaved form of the subunit was, if anything, decreased by the drug, in the opposite direction from the amiloride effect, although the change was not statistically significant. Thus the preservation of ENaC expression observed with amiloride was likely due to blocking Na ϩ entry and presumably preventing increased [Na ϩ ] i .
DISCUSSION
Increased aldosterone plays a critical role in mediating the signal of low blood volume and low Na ϩ intake to the ASDN Fig. 7 . Cell-surface expression of NHE3, NKCC2, and NCC for control and resalted rats. Cell-surface expression of 160-kDa (P ϭ 0.2), 75-kDa (P ϭ 0.9), or total (P ϭ 0.5) NHE3 (A and B) ; 280-kDa NKCC2 (P ϭ 0.99) (C and D) ; or 260-kDa (P ϭ 0.4), 160-kDa (P ϭ 0.07), or total (P ϭ 0.09) NCC did not significantly change; n ϭ 4 for all conditions. to upregulate sodium reabsorption and maintain blood volume. Conversely, during a high Na ϩ intake, serum aldosterone levels quickly decrease (6, 27) . However, we show here that this rapid decrease in aldosterone is not necessary to downregulate ENaC activity in response to an acute sodium load (Figs. 2 and 3A) . In a previous study using single-channel recordings of ENaC from salt-restricted rat CCD, Pàcha et al. (27) showed that channel activity decreased ϳ50% relative to nonresalted controls after a 12-h sodium load even with aldosterone infusion, qualitatively similar to the results presented here.
Acute sodium repletion decreased levels of cleaved ␣-and ␥-ENaC in the whole kidney, and also reduced cell-surface expression of cleaved ␥-ENaC (Figs. 4 and 5) . The cleaved forms of ␣ (9, 10, 20) and ␥ (4, 8, 31) ENaC have previously been identified with the active form of the channel. In addition, there was a decrease in the maturely glycosylated form of ␤-ENaC in both the whole kidney and cell surface, but the functional significance of that change has yet to be determined.
The effects of resalting on protein expression were specific to ENaC; there were little to no changes in NHE3, NKCC2, and NCC (Figs. 6 and 7) . This does not rule out decreases in the activity of these transporters. Acute sodium repletion would lead to rapid decreases in angiotensin II, a hormone that other studies found can increase phosphorylation and presum- (A and B) , did not change whole kidney expression of ␤-ENaC (P ϭ 0.9) (C and D), and increased whole kidney expression of cleaved (P ϭ 0.02) but not uncleaved ␥-ENaC (P ϭ 0.99) (E and F). *Statistical significance compared with resalted rats; n ϭ 4 for all conditions. ably the activity of NCC (36, 42) . However, such regulation appears not to involve reduction in surface expression.
Increased Na ϩ entry into the principal cells secondary to increased Na ϩ delivery to the ASDN is another candidate for mediating the effects of resalting on ENaC. Increased [Na ϩ ] i serves as an important signal to decrease ENaC activity and limit Na ϩ entry into the cell to help preserve cell volume.
Previous in vitro studies documented downregulation of the channels in response to increased intracellular Na ϩ , a process known as "feedback inhibition" (1-3). Whether this phenomenon occurs in vivo has not been established.
To address this question we implanted an amiloride-containing mini-pump prior to the sodium load to inhibit Na entry. Amiloride prevented decreases in whole-kidney expression of . Whole-kidney expression of ␥-ENaC in Na-replete rats with or without HCTZ treatment. Animals were Na-depleted, infused with aldosterone, and saline as drinking water for 4 h after injection of HCTZ or diluent. HCTZ did not significantly change the expression of uncleaved (P ϭ 0.7), cleaved (P ϭ 0.14) or total (P ϭ 0.2) ␥-ENaC.
cleaved ␣-and ␥-ENaC and cell-surface expression of ␤-ENaC and cleaved ␥-ENaC (Figs. 8 and 9 ). This effect was not observed with thiazide treatment, suggesting that the action of amiloride was due to decreased entry of Na ϩ in the principal cells rather than to increased rates of Na ϩ excretion. This interpretation is tentative in that neither rates of entry nor intracellular Na ϩ concentrations were directly measured. Despite an increase in ENaC expression seen with amiloride treatment during an acute sodium load, the aldosterone-independent decrease in I Na remained intact, revealing a dissociation between channel surface expression and activity. A number of different signaling pathways could contribute to the regulation of channels at the cell surface. Plasma angiotensin II levels should decrease under these conditions, and there is recent evidence that angiotensin II can acutely upregulate ENaC open probability (P o ) (25, 33, 39) . However, this effect quickly reverses and would most likely dissipate by the time the kidney is removed to the time that whole cell recordings are made. A recent paper suggests that endothelin-1 (ET-1) production in the CCD is directly correlated with Na ϩ delivery and tubular flow rate (30) . As ET-1 has been shown to be a potent inhibitor of ENaC activity (5, 32) , it is another potential regulator of I Na during acute sodium loading. Finally, purinergic signaling via ATP and UTP has been shown to decrease ENaC P o (34, 46) . This signaling is under the control of dietary sodium (35) and is thought to mediate downregulation of ENaC in the presence of high aldosterone during high Na ϩ intake (38) . These data make purinergic signaling another possible mediator of I Na inhibition during acute sodium loading.
In summary, we provide evidence for aldosterone-independent downregulation of ENaC in response to an acute sodium load. When entry of Na ϩ into principal cells is permitted, inhibition of ENaC activity was accompanied by parallel decreases in whole kidney expression of all three ENaC subunits and cell-surface expression of ␤-and ␥-ENaC without significant changes in other sodium transporters in the nephron. Blocking Na ϩ entry with amiloride protected against changes in whole kidney expression of ␣-and ␥-ENaC and cell-surface expression of ␤-and ␥-ENaC presumably by decreasing [Na ϩ ] i but did not significantly change the decrease in I Na in response to an acute sodium load. Further investigations will be necessary to identify the mediators of I Na inhibition under these conditions.
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